DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Elspar (Asparaginase) - News

 
 



News related to Elspar (Asparaginase) and/or conditions it is approved for

Halting lethal childhood leukemia
Source: Genetics News From Medical News Today [2017.01.10]
Northwestern Medicine scientists have discovered the genetic driver of a rare and lethal childhood leukemia and identified a targeted molecular therapy that halts the proliferation of leukemic...

Obesity-associated protein could be linked to leukemia development
Source: Biology / Biochemistry News From Medical News Today [2016.12.30]
Cancer researchers at the University of Cincinnati (UC) College of Medicine have found an obesity-associated protein's role in leukemia development and drug response which could lead to more...

Fasting could help treat most common childhood leukemia
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2016.12.13]
A study reveals that intermittent fasting cleared cancer cells and increased survival in mouse models of acute lymphocytic leukemia.

Side effects of leukemia drug can be safely reduced by halving dose
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2016.12.08]
Patients with a chronic type of leukaemia could safely reduce the side effects of life-long treatment by cutting their dose in half, according to the results of a University of Liverpool led study...

Therapeutic Vaccine Shows 'Game-Changing' Promise Against a Leukemia
Source: MedicineNet Leukemia Specialty [2016.12.08]
Title: Therapeutic Vaccine Shows 'Game-Changing' Promise Against a Leukemia
Category: Health News
Created: 12/7/2016 12:00:00 AM
Last Editorial Review: 12/8/2016 12:00:00 AM

In highly lethal type of leukemia, cancer gene predicts treatment response
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2016.11.25]
Patients with the most lethal form of acute myeloid leukemia (AML) - based on genetic profiles of their cancers - typically survive for only four to six months after diagnosis, even with aggressive...

Potential targeted therapy found for newly identified leukemia subtype with poor outcome
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2016.11.10]
An international research team led by St. Jude Children's Research Hospital investigators has uncovered details of a new, high-risk subtype of acute lymphoblastic leukemia (ALL) as well as a...

Genetic hallmarks of acute lymphoblastic leukemia subtype uncovered
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2016.10.25]
St. Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project team identifies genetic changes underlying a type of B-precursor acute lymphoblastic leukemiaAn...

Leukemia
Source: MedicineNet Eosinophilic Fasciitis Specialty [2016.02.03]
Title: Leukemia
Category: Diseases and Conditions
Created: 12/31/1997 12:00:00 AM
Last Editorial Review: 2/3/2016 12:00:00 AM

New benchmark study of unrelated bone marrow transplantation for leukemia
Source: The Doctors Lounge - Hematology
Researchers at the University of Minnesota led the largest study to date in patients with leukemia undergoing bone marrow transplantation from unrelated donors.

Study Supports Viral Origin for Some ALL (CME/CE)
Source: MedPage Today Oncology/Hematology [2017.01.08]
(MedPage Today) -- CMV infection at birth more than tripled leukemia risk

Infant's prolonged infection reveals mutation that helps bacteria tolerate antibiotics
Source: Immune System / Vaccines News From Medical News Today [2017.01.04]
The quest to understand a prolonged infection in an infant being treated for leukemia has led to the St.

Congenital herpes virus tied to common childhood cancer
Source: Pregnancy / Obstetrics News From Medical News Today [2016.12.19]
Children who develop acute lymphoblastic leukemia are over three times more likely to have tested positive for cytomegalovirus at birth, a new study shows.

Nivolumab with chemotherapy improves response, survival in AML study patients
Source: Clinical Trials / Drug Trials News From Medical News Today [2016.12.06]
The immunotherapy drug nivolumab in combination with standard chemotherapy more than doubled response rates and improved overall survival in patients with acute myeloid leukemia (AML), according to...

Prevalence of Ph-like ALL in adults underscores need for genetic testing, clinical trials
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2016.11.22]
A high-risk subtype of acute lymphoblastic leukemia (ALL) first identified in children is highly prevalent in adults with ALL and is associated with a poor outcome, according to an international...

Researchers develop new strategy to limit side effects of stem cell transplants
Source: Transplants / Organ Donations News From Medical News Today [2016.08.16]
Scientists in Germany have developed a new approach that may prevent leukemia and lymphoma patients from developing graft-versus-host disease (GvHD) after therapeutic bone marrow transplants.

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015